551 related articles for article (PubMed ID: 19674113)
1. Cystic fibrosis infections: treatment strategies and prospects.
George AM; Jones PM; Middleton PG
FEMS Microbiol Lett; 2009 Nov; 300(2):153-64. PubMed ID: 19674113
[TBL] [Abstract][Full Text] [Related]
2. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
Treerat P; Widmer F; Middleton PG; Iredell J; George AM
FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
[TBL] [Abstract][Full Text] [Related]
3. [Bacterial infections and resistance to antibiotics in cystic fibrosis].
Taccetti G; Repetto T; Procopio E; Marianelli L; Campana S
Pediatr Med Chir; 1999; 21(5 Suppl):213-8. PubMed ID: 10963010
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
Hata JS; Fick RB
Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
[TBL] [Abstract][Full Text] [Related]
5. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
[TBL] [Abstract][Full Text] [Related]
6. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
Govan JR; Brown AR; Jones AM
Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
[TBL] [Abstract][Full Text] [Related]
7. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
8. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
Lynch JP
Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic use in cystic fibrosis.
Eisenberg JD
Curr Opin Pulm Med; 1996 Nov; 2(6):439-46. PubMed ID: 9363182
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
Zabner R; Quinn JP
Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
[TBL] [Abstract][Full Text] [Related]
12. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
Banerjee D; Stableforth D
Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
[TBL] [Abstract][Full Text] [Related]
13. Temocillin in cystic fibrosis: a retrospective pilot study.
Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
[TBL] [Abstract][Full Text] [Related]
14. The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN; Ratjen F
Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
[TBL] [Abstract][Full Text] [Related]
15. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
Dales L; Ferris W; Vandemheen K; Aaron SD
Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248
[TBL] [Abstract][Full Text] [Related]
16. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A; Gyi KM; Hodson ME
J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
Horsley A; Jones AM
Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
[TBL] [Abstract][Full Text] [Related]
18. [Cystic fibrosis and pseudomonas aeruginosa current and future strategies].
Leonard A; Leal T; Lebecque P
J Pharm Belg; 2007; 62(1):25-8. PubMed ID: 17508664
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
20. [Bacterial infections of the lungs in mucoviscidosis patients].
Hogardt M; Heesemann J
MMW Fortschr Med; 2005 Jan; 147(4):38-40. PubMed ID: 15745340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]